SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-18-009871
Filing Date
2018-04-30
Accepted
2018-04-30 16:54:11
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 2017 10-K/A mlnt-10ka_20171231.htm 10-K/A 2396763
2 EX-31.1 mlnt-ex311_27.htm EX-31.1 17219
3 EX-31.2 mlnt-ex312_26.htm EX-31.2 17517
  Complete submission text file 0001564590-18-009871.txt   2432714
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35405 | Film No.: 18790768
SIC: 2834 Pharmaceutical Preparations